@article{1f7f1b4a43ff410e8c3ae34fef5c8854,
title = "Super-Responders to Severe Asthma Treatments: Defining a New Paradigm",
author = "Hitasha Rupani and Mark Hew",
note = "Funding Information: Conflicts of interest: H. Rupani has received grants and speaker fees from AstraZeneca, GlaxoSmithKline, Novartis, and Teva. M. Hew has received grants, speaker fees, and advisory board fees from GlaxoSmithKline, AstraZeneca, Novartis, Teva, Sanofi, and Seqirus, all paid to his institutional employer, Alfred Health.",
year = "2021",
month = nov,
doi = "10.1016/j.jaip.2021.08.014",
language = "English",
volume = "9",
pages = "4005--4006",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier BV",
number = "11",
}